Investigation of a neuropsychological screen for chemo-fog

Oncology Reviews

Volumn 5, Issue 4, 2011, Pages 205-213

  Ouimet, Lea Ann ^a   Stewart, Angela ^b   Collins, Barbara ^c   Schindler, Dwayne ^a   Bielajew, Catherine ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ROYAL OTTAWA HEALTH CARE GROUP   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Breast cancer; Chemotherapy; Cognitive impairment; Misdiagnosis; Neuropsychological assessment

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; APTITUDE TEST; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER SCREENING; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW;

EID: 83555174604     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-011-0090-3     Document Type: Review

References (34)

1. LA Ouimet A Stewart B Collins D Schindler C Bielajew 2009 Measuring neuropsychological change following breast cancer: an analysis of statistical models J Clin Exp Neuropsychol 31 73 89 18608651 10.1080/13803390801992725 1:STN:280:DC%2BD1M%2FhsFSrsg%3D%3D
2. Canadian Cancer Society (2010) Breast cancer statistics. http://www.cancer.ca/Canada-wide/About%20cancer/Cancer%20statistics/ Stats%20at%20a%20glance/Breast%20cancer.aspx?sc-lang=en. Accessed 11 Sept 2010
3. American Cancer Society (2010) How many women get breast cancer? http://www.cancer.org/Cancer/BreastCancer/OverviewGuide/breast-cancer-overview- key-statistics. Accessed 11 Sept 2010
4. J Abraham MW Haut MT Moran S Filburn S Lemiuex H Kuwabara 2008 Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging Clin Breast Cancer 8 88 91 18501063 10.3816/CBC.2008.n.007 (Pubitemid 351346234)
5. B Collins J Mackenzie A Stewart C Bielajew S Verma 2008 Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment Psychooncology 18 134 143
6. J Debess JO Riss MC Engebjerg M Ewertz 2010 Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study Breast Cancer Res Treat 121 91 100 20306129 10.1007/s10549-010-0756-8 1:CAS:528:DC%2BC3cXkvVymtLk%3D
7. RJ Ferguson TA Ahles AJ Saykin BC McDonald CT Furstenberg BF Cole 2007 Cognitive-behavioral management of chemotherapy-related cognitive change Psychooncology 16 772 777 17152119 10.1002/pon.1133 (Pubitemid 47249179)
8. K Hermelink M Untch MP Lux R Kreienberg T Beck I Bauerfeind K Munzel 2007 Cognitive function during neoadjuvant chemotherapy for breast cancer Cancer 109 1905 1913 17351951 10.1002/cncr.22610 1:CAS:528:DC%2BD2sXlsF2msr4%3D (Pubitemid 46668557)
9. A Hurria M Lachs 2007 Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer? Breast Cancer Res Treat 103 259 268 17429718 10.1007/s10549-006-9383-9 1:CAS:528:DC%2BD2sXmsVOjur0%3D (Pubitemid 46944514)
10. CE Jansen CA Miaskowski MJ Dodd GA Dowling 2007 A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairments in patients with breast cancer Oncol Nurs Forum 34 997 1005 17878128 10.1188/07.ONF.997-1005
11. HSL Jim KA Donovan BJ Small MA Andrykowski PN Munster PB Jacobsen 2009 Cognitive functioning in breast cancer survivors: a controlled comparison Cancer 115 1776 1783 19224550 10.1002/cncr.24192
12. SR Kesler FC Bennett ML Mahaffey D Spiegel 2009 Regional brain activation during verbal declarative memory in metastatic breast cancer Clin Cancer Res 15 6665 6673 19843664 10.1158/1078-0432.CCR-09-1227 1:CAS:528:DC%2BD1MXhtlCjsrfN
13. SA Reid-Arndt A Yee MC Perry C Hsieh 2009 Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors J Psychosoc Oncol 27 415 434 19813133 10.1080/07347330903183117
14. A Stewart B Collins J Mackenzie E Tomiak S Verma C Bielajew 2008 The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study Psychooncology 17 122 130 17518411 10.1002/pon.1210 (Pubitemid 351279862)
15. FA Tager PS McKinley FR Schnabel M El-Tamer YK Cheung Y Fang CR Golden ME Frosch U Habif MM Mulligan IS Chen DL Hershman 2010 The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study Breast Cancer Res Treat 123 25 34 19894112 10.1007/s10549-009-0606-8
16. S Taillibert D Voillery C Bernard-Marty 2007 Chemobrain: is systemic chemotherapy neurotoxic? Curr Opin Oncol 19 623 627 17906463 10.1097/CCO.0b013e3282f0e224 (Pubitemid 47508872)
17. TA Ahles AJ Saykin CT Furstenberg B Cole LA Mott L Titus-Ernstoff K Skalla M Bakitas PM Silberfarb 2005 Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy J Clin Oncol 23 4399 4405 15994149 10.1200/JCO.2005.03.343 1:CAS:528:DC%2BD2MXms12gs7c%3D (Pubitemid 46207014)
18. FP Downie HG Mar Fan A Tchen Q Yi IF Tannock 2006 Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment Psychooncology 15 921 930 16477674 10.1002/pon.1035 (Pubitemid 44612891)
19. LJ Fallowfield SK Leaity A Howell S Benson D Cella 1999 Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B Breast Cancer Res Treat 55 189 199 10481946 10.1023/A:1006263818115 1:STN:280:DyaK1MvgvFKksA%3D%3D (Pubitemid 29389581)
20. AE Kayl JS Wefel CA Meyers 2006 Chemotherapy and cognition: effects, potential mechanisms, and management Am J Ther 12 362 369 10.1097/00045391- 200607000-00013 (Pubitemid 44492257)
21. HG Mar Fan N Houede-Tchen Q Yi I Chemerynsky FP Downie K Sabate IF Tannock 2005 Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1 and 2 year follow-up of a prospective controlled study J Clin Oncol 23 8025 8032 10.1200/JCO.2005.01.6550 (Pubitemid 46657404)
22. A Mehnert A Scherwath L Schirmer B Schleimer C Peterson F Schulz-Kindermann A Zander U Koch 2007 The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy Patient Educ Couns 66 108 118 17320337 10.1016/j.pec.2006.11.005 (Pubitemid 46366616)
23. D Von Ah KM Russell AM Storniolo JS Carpenter 2009 Cognitive dysfunction and its relationship to quality of life in breast cancer survivors Oncol Nurs Forum 36 326 336 10.1188/09.ONF.326-334
24. J Weis M Poppelreuter HH Bartsch 2009 Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results Psychooncology 18 775 782 19061196 10.1002/pon.1472 1:STN:280:DC%2BD1MvmtVeqtw%3D%3D
25. TM Wong 2006 Ethical controversies in neuropsychological test selection, administration, and interpretation Appl Neuropsychol 13 68 76 17009880 10.1207/s15324826an1302-2 (Pubitemid 44618494)
26. Strauss E, Sherman E, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary, 3rd edn. Oxford University Press, New York
27. AJ McSweeney RI Naugle GJ Chelune H Lunders 1993 "T scores for change": an illustration of a regression approach to depicting change in clinical neuropsychology Clin Neuropsychol 7 300 312 10.1080/13854049308401901 (Pubitemid 23279991)
28. Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, 4th edn. Oxford University Press, New York
29. JR Freeman DK Broshek 2002 Assessing cognitive dysfunction in breast cancer: what are the tools? Clin Breast Cancer 3 591 599 10.3816/CBC.2002.s.019
30. Lucas J, Addeo RR (2005) Traumatic brain injury and post-concussive syndrome. In: Snyder PJ, Nussbaum PD (eds) Clinical neuropsychology: a pocket handbook for assessment, 2nd edn. American Psychological Association, Washington, DC, pp 351-380
31. CM Bender SM Sereika SL Berga VG Vogel AM Brufsky KK Paraska CM Ryan 2006 Cognitive impairment associated with adjuvant therapy in breast cancer Psychooncology 15 422 430 16097037 10.1002/pon.964 (Pubitemid 43826855)
32. SA Castellon PA Ganz JE Bower L Peterson L Abraham GA Greendale 2004 Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen J Clin Exp Neuropsychol 26 955 969 15742545 10.1080/13803390490510905 (Pubitemid 39577316)
33. FS van Dam SB Schagen MJ Muller W Boogerd E Wall ME Droogleever Fortuyn S Rodenhuis 1998 Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy J Natl Cancer Inst 90 210 218 9462678 10.1093/jnci/90.3.210 (Pubitemid 28114539)
34. SM Sawrie 2002 Analysis of cognitive change: a commentary on Keith et al. (2002) Neuropsychology 16 429 431 12146691 10.1037/0894-4105.16.3.429 (Pubitemid 34778910)